Related Experiment Videos
[Cerebral vasospasm caused by subarachnoid hemorrhage]
Minerva Medica
|June 8, 1986
Summary
Subarachnoid hemorrhage (SAH) can lead to vasospasm, causing severe neurological deficits. Understanding the biochemical triggers and effective treatments like calcium antagonists is crucial for preventing ischemic complications.
Area of Science:
- Neuroscience
- Biochemistry
Context:
- Vasospasm is a frequent and severe complication following subarachnoid hemorrhage (SAH).
- It leads to high mortality and significant neurological deficits, often resulting in disability.
- Diagnosis relies on clinical timing (3-8 days post-SAH) and angiographic confirmation.
Purpose:
- To review the primary pathogenetic theories of vasospasm following SAH.
- To identify key biochemical substances involved in vasospasm genesis.
- To discuss current treatment strategies aimed at preventing ischemic complications.
Summary:
- The etiology of SAH-induced vasospasm is multifactorial, with blood in the subarachnoid space playing a central role.
- Key biochemical factors include oxyhemoglobin, free radicals, lipid peroxides, and arachidonic acid metabolites.
- Early aneurysm exclusion and pharmacological treatments, particularly calcium antagonists, show promise.
Impact:
- Improved understanding of SAH vasospasm mechanisms.
- Guidance for developing targeted therapeutic interventions.
- Potential to reduce mortality and long-term disability associated with SAH.